Studies also show that EPAC signaling can help cancer cells move by increasing the expression of histone deacetylase 6 (HDAC6) [155] or by making it easier for β-catenin to move into the nucleus and increase transcription [154] in lung cancer cells. Here, HDAC6 is linked to lung carcinoma.